Shanmuga Hospital Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹3(5.56%)
Premium (ELP)
The Initial Public Offering of Shanmuga Hospital Limited's culminated in its successful listing on Feb 21, 2025 at the BSE trading platform. The company secured 38,18,000 Shares through this capital market exercise, with 38,18,000 Shares allocated to new capital formation.
Investors participated within the price parameters of ₹54 to ₹54, with minimum investment requirements of 2000 shares. The subscription period from Feb 13, 2025 to Feb 17, 2025 witnessed active investor engagement across categories.
Following the subscription closure, share allotment was processed on Feb 18, 2025. The subsequent listing established a public market for the company's shares, enabling price discovery and secondary market trading for investors.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Established in 2020, Shanmuga Hospital Limited is a NABH and NABL-accredited multispecialty hospital in Salem, Tamil Nadu, offering preventive, treatment, and rehabilitation services with advanced medical technology and 151 beds. Located on Saradha College Road, the hospital covers 45,311 sq. ft. across two blocks and three floors, providing both inpatient and outpatient care. It also operates Shanmuga Pharmacy & Diagnostics for medicines and pathology services, and Shanmuga Clinics for specialized consultations and patient transfers. The hospital’s key specialties include oncology, general surgery, orthopaedics, cardiology, paediatrics, neurology, endocrinology, and respiratory medicine. As of August 2024, it employed 72 doctors, including resident, consulting, and visiting specialists.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Expert Cancer Care – Specializes in cancer treatment with advanced facilities, earning a strong reputation in the region.
- Trusted Leadership – Led by experienced professionals with 40+ years in healthcare, ensuring steady growth and reliability.
- Affordable Treatment – Offers high-quality medical care at reasonable prices, making healthcare accessible to more people.
- Legal Issues – Ongoing court cases involving the company, its directors, and promoters could hurt business and finances if the decisions don’t go in their favor.
- Short Track Record – The company started in 2020, so investors may find it hard to judge its long-term growth and financial health.
- Reliance on Medical Staff – The hospital depends on doctors and nurses, many of whom work as consultants. If it struggles to hire or keep them, its operations and service quality could suffer.
- Dr. Panneerselvam Palaniappan Shanmugam
- Dr. Prabu Sankar Panneerselvam
- Dr. Priyadharshni Dhandapani
- Mrs. Jayalakshmi Panneerselvam
Shanmuga Hospital Limited
Integrated Registry Management Services Private Limited